Medical Devices Investors & VC Firms in Asia-Pacific

420 firms in this list, with a median first check of $500K. 82 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
CH Chang'an Capital SXXQTW3 people	88🔒	Beijing	CN	Seed–Series B	—	+ Add to CRM
CB CBC Group WFJM2 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
IN INCJ, Ltd. MK1 person	88🔒	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
GL Global Venture Capital, Inc. HHMJ2 people	88🔒	Tokyo	JP	Seed–Series A	—	+ Add to CRM
SH Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd. FZJL2 people	88🔒	Shenzhen	CN	Seed–Series B	—	+ Add to CRM
TO Tohoku Innovation Capital Corporation KIKK2 people	88🔒	Miyagi	JP	Seed–Series A	—	+ Add to CRM
HE Hermes-Epitek FL1 person	88🔒	Hsinchu	TW	Seed	—	+ Add to CRM
SH Shanghai STVC Group MZ1 person	88🔒	Shanghai	CN	Seed–Growth	—	+ Add to CRM
VE Venture Labo Investment	88🔒	Tokyo	JP	Seed–Series A	—	+ Add to CRM
DO Dooghoon Investment Co. ST1 person	88🔒	Seoul	KR	Seed–Series A	—	+ Add to CRM
IL Ilshin Investment Co. Ltd. JK1 person	88🔒	Seoul	KR	Seed–Late Stage	—	+ Add to CRM
3H 3H Health Investment	88🔒	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
ZE Zero2IPO	88🔒	Beijing	CN	Series A–Late Stage	—	+ Add to CRM
AL Alumni Ventures BOJGLAMC111 people · Follows rounds	88🔒	Manchester	US	Pre-Seed–Late Stage	$100K – $10M	+ Add to CRM
NO Norwest Venture Partners TAAHCSDZ185 people · Leads rounds	88🔒	Menlo Park	US	Seed–Late Stage	$10M – $30M	+ Add to CRM
TA TA Associates ANAAHDJW216 people	88🔒	Boston	US	Growth	—	+ Add to CRM
KH Khosla Ventures VKDWSKKR49 people · Leads rounds	88🔒	Menlo Park	US	Pre-Seed–Growth	$100K – $20M	+ Add to CRM
F- F-Prime Capital APBCCXJA110 people · Leads rounds	88🔒	Cambridge	US	Pre-Seed–Series C	$3M – $10M	+ Add to CRM
OR OrbiMed ABASDBDW93 people · Leads rounds	88🔒	New York	US	Seed–Late Stage	$1M – $75M	+ Add to CRM
B B Capital Group BVDCESEW99 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Late Stage	$10M – $50M	+ Add to CRM
PI PICUS CAPITAL ASASABCO111 people · Follows rounds	88🔒	Munich	DE	Pre-Seed–Series B	$100K – $5M	+ Add to CRM
VU VU Venture Partners AZJSBGDL116 people · Leads rounds	88🔒	San Francisco	US	Seed–Series B	$200K – $1M	+ Add to CRM
FR Frazier Life Sciences AFAKACAH77 people · Leads rounds	88🔒	Palo Alto	US	Seed–Late Stage	—	+ Add to CRM
AR ARCH Venture Partners CBKCMMPT46 people · Follows rounds	88🔒	Chicago	US	Seed–Series C	$50K – $250M	+ Add to CRM

Chang'an Capital

BeijingSeed–Series B

SXXQTW3 people

CBC Group

SingaporeSeed–Late Stage

WFJM2 people

INCJ, Ltd.

TokyoSeed–Late Stage

MK1 person

Global Venture Capital, Inc.

TokyoSeed–Series A

HHMJ2 people

Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.

ShenzhenSeed–Series B

FZJL2 people

Tohoku Innovation Capital Corporation

MiyagiSeed–Series A

KIKK2 people

Hermes-Epitek

HsinchuSeed

FL1 person

Shanghai STVC Group

ShanghaiSeed–Growth

MZ1 person

Venture Labo Investment

TokyoSeed–Series A

Dooghoon Investment Co.

SeoulSeed–Series A

ST1 person

Ilshin Investment Co. Ltd.

SeoulSeed–Late Stage

JK1 person

3H Health Investment

ShanghaiSeries A–Late Stage

Zero2IPO

BeijingSeries A–Late Stage

Alumni Ventures

ManchesterPre-Seed–Late Stage$100K – $10M

BOJGLAMC111 people

Norwest Venture Partners

Menlo ParkSeed–Late Stage$10M – $30M

TAAHCSDZ185 people

TA Associates

BostonGrowth

ANAAHDJW216 people

Khosla Ventures

Menlo ParkPre-Seed–Growth$100K – $20M

VKDWSKKR49 people

F-Prime Capital

CambridgePre-Seed–Series C$3M – $10M

APBCCXJA110 people

OrbiMed

New YorkSeed–Late Stage$1M – $75M

ABASDBDW93 people

B Capital Group

San FranciscoPre-Seed–Late Stage$10M – $50M

BVDCESEW99 people

PICUS CAPITAL

MunichPre-Seed–Series B$100K – $5M

ASASABCO111 people

VU Venture Partners

San FranciscoSeed–Series B$200K – $1M

AZJSBGDL116 people

Frazier Life Sciences

Palo AltoSeed–Late Stage

AFAKACAH77 people

ARCH Venture Partners

ChicagoSeed–Series C$50K – $250M

CBKCMMPT46 people

Data sourced from public filings and firms' own websites — see our methodology.